English
Lentivirus est genus vectoris viralis ab homine immunodeficientiae (HIV) mutatum, quod genus retrovirus est. In experimentis vitro et experimentis vivo, lentivirus factus est unus e usitatis vectorum formis ad exprimendum genes exogenosa vel exogenosa shRNA, et latius adhibetur. In massa productione, the@_@ cellae culturae consumabilis communiter adhibita est. vector lentiviralis efficaciter potest integrare gena exogenosa vel shRNAs exogenas in chromosomatum exercitum, ita ut effectum obtineat clypeum pertinaciter exprimendi. sequentia. Secundum infectiolitatem cellulis neuronalibus, hepatocytis, cardiomyocytis, cellulis tumoribus, cellulis endothelialibus, caule cellulis et aliis generibus cellularum inficere potest, ut effectus bonos gene therapiae consequantur. Pro nonnullis cellulis difficilibus-transfectis, ut sunt cellulae primariae, cellulae caulis, cellulae indifferentiatae, etc., usus vectoris lentiviralis multum emendare potest ad efficientiam traductionis scopo gene vel scopae shRNA, et scopum gene vel scopum shRNA potest. integrari in cellam hospes. Probabilitas genome valde augetur, et diuturna et stabilis significatio signi gene vel scopae shRNA commodius et velocius intellegi potest. officinas cellae
Officina cellae maxime applicatur ad productionem vectoris lentiviralis amplificatam. Superficies culturae cellae augere potest, cede vectoris augens, pluries minuens translationis et mediae post-transactionis substitutionem et laboris impensas minuens. Est efficax et conveniens culturae cellae consumabilis.
Praeter quod applicatur ad productionem magnam vectoris lentiviralis, officinas cellularum magni ponderis partes agunt in magna-scalarum productione cellae justo, gene therapia, virus oncolyticum ac vaccina.
In addition to being applied to the large-scale production of lentiviral vectors, cell factories play an important role in the large-scale production of cell therapy, gene therapy, oncolytic virus therapy, and vaccines.
The FAI climbed 5.9 percent year-on-year in the first 11 months of 2018, quickening from the 5.7-percent growth in Jan-Oct, the National Bureau of Statistics (NBS) said Friday in an online statement.
The key indicator of investment, dubbed a major growth driver, hit the bottom in August and has since started to rebound steadily.
In the face of emerging economic challenges home and abroad, China has stepped up efforts to stabilize investment, in particular rolling out measures to motivate private investors and channel funds into infrastructure.
Friday's data showed private investment, accounting for more than 60 percent of the total FAI, expanded by a brisk 8.7 percent.
NBS spokesperson Mao Shengyong said funds into weak economic links registered rapid increases as investment in environmental protection and agriculture jumped 42 percent and 12.5 percent respectively, much faster than the average.
In breakdown, investment in high-tech and equipment manufacturing remained vigorous with 16.1-percent and 11.6-percent increases respectively in the first 11 months. Infrastructure investment gained 3.7 percent, staying flat. Investment in property development rose 9.7 percent, also unchanged.